Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-011567
Filing Date
2010-02-23
Accepted
2010-02-23 19:37:44
Documents
2
Period of Report
2010-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9310
2 POA DOCUMENT poa.txt EX-24.3_319000 3957
  Complete submission text file 0001209191-10-011567.txt   15022
Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
HENNEY CHRISTOPHER S (Reporting) CIK: 0001242880 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34637 | Film No.: 10627952

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations